These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15694026)

  • 21. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
    Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.
    Li HG; Xie DR; Shen XM; Li HH; Zeng H; Zeng YJ
    World J Gastroenterol; 2005 Mar; 11(10):1445-51. PubMed ID: 15770719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
    Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
    Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma].
    Wang W; Yang LY; Huang GW; Yang ZL; Lu WQ; Peng JX; Yang JQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):279-82. PubMed ID: 15312362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
    Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
    Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma].
    Qin J; Wang ZW; Ni QC; Wang Y; Chen L; Lu MD; Shen AG
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2533-6. PubMed ID: 19080643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
    Du JL; Wang YL; Shi HY; Guo AT; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
    Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
    Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
    Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of novel metastasis-promoting gene 1 and its clinical significance in hepatocellular carcinoma].
    Li J; Huang Y; Yang D; Liang B; He H; Liao H; Guo B; Liu X; Lin L
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1530-3. PubMed ID: 25146738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.